Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Insulet Corporation - Common Stock (NQ:PODD)

282.64 -0.28 (-0.10%)
Streaming Delayed Price Updated: 1:53 PM EST, Jan 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Insulet Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
News headline image
3 Reasons Investors Love Insulet (PODD)
Insulet has had an impressive run over the past six months as its shares have beaten the S&P 500 by 18%. The stock now trades at $337, marking a 35.7% gain. This was partly thanks to its solid... 
Via StockStory
Topics Stocks
News headline image
ResMed, Insulet, Lantheus, Inspire Medical Systems, and Evolent Health Shares Plummet, What You Need To Know
A number of stocks fell in the afternoon session after markets pulled back, reversing early gains, as investor sentiment remained cautious despite a softer-than-expected inflation reading. 
Via StockStory
Topics Economy
News headline image
Which S&P500 stocks are moving on Wednesday? ↗
Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Wednesday. 
Via Chartmill
News headline image
Is the Market Bullish or Bearish on Insulet? ↗
 
Via Benzinga
News headline image
These S&P500 stocks are gapping in today's session ↗
Let's take a look at the S&P500 stocks that are experiencing notable price gaps in today's session on Wednesday. Discover the gap up and gap down stocks in the S&P500 index. 
Via Chartmill
News headline image
Insulet Corp (NASDAQ:PODD) Combines Technical Strength and Fundamental Momentum for High-Growth Potential ↗
Insulet Corp (PODD) combines strong technical uptrends with accelerating earnings and revenue growth, making it a top high-growth momentum stock. 
Via Chartmill
News headline image
3 S&P 500 Stocks to Target This Week
The S&P 500 (^GSPC) is packed with companies that have built dominant market positions, making it a core index for investors. A select few continue to innovate and expand, setting themselves up for... 
Via StockStory
Topics Stocks
News headline image
Assessing Insulet: Insights From 6 Financial Analysts ↗
 
Via Benzinga
News headline image
$100 Invested In This Stock 15 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
2 Mid-Cap Stocks Worth Your Attention and 1 We Ignore
Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from... 
Via StockStory
News headline image
3 Cash-Producing Stocks to Target This Week
Cash-generating companies often have the flexibility to invest, return capital to shareholders, or navigate downturns. The best of these businesses not only accumulate cash but deploy it strategically... 
Via StockStory
News headline image
Patient Monitoring Stocks Q2 Highlights: Insulet (NASDAQ:PODD)
As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the patient monitoring industry, including Insulet (NASDAQ:PODD) and its peers. 
Via StockStory
Topics Artificial Intelligence
News headline image
Insulet Elevates Eric Benjamin to Chief Operating Officer
From Insulet Corporation
Via Business Wire
News headline image
2 Surging Stocks with Exciting Potential and 1 We Brush Off
Exciting developments are taking place for the stocks in this article. They’ve all surged ahead of the broader market over the last month as catalysts such as new products and positive media coverage... 
Via StockStory
News headline image
2 Growth Stocks to Add to Your Roster and 1 Facing Headwinds
Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived through the 2020 to 2022 COVID cycle. 
Via StockStory
News headline image
Demystifying Insulet: Insights From 7 Analyst Reviews ↗
 
Via Benzinga
News headline image
Cisco, Rocket Companies, Insulet And More On CNBC's 'Final Trades' ↗
Lending support to his choice, BTIG analyst initiated coverage on Rocket Companies with a Buy rating and $25 price target. Cisco and Insulet also discussed. 
Via Benzinga
News headline image
Insulet to Participate in Upcoming Investor Conferences
From Insulet Corporation
Via Business Wire
News headline image
Here's How Much You Would Have Made Owning Insulet Stock In The Last 15 Years ↗
 
Via Benzinga
News headline image
2 Safe-and-Steady Stocks for Long-Term Investors and 1 We Brush Off
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere. 
Via StockStory
News headline image
Insulet Corp (NASDAQ:PODD) Fits Minervini’s Trend Template with Strong Growth Momentum ↗
Insulet Corp (PODD) aligns with Minervini's high-growth momentum strategy, showing strong technical uptrends, robust earnings growth, and solid revenue expansion. A top pick for investors seeking... 
Via Chartmill
News headline image
PODD Q2 Deep Dive: Omnipod 5 Adoption and International Expansion Drive Results
Insulin delivery company Insulet Corporation (NASDAQ:PODD) reported Q2 CY2025 results beating Wall Street’s revenue expectations, with sales up 32.9% year on year to $649.1 million. On top of that,... 
Via StockStory
Topics World Trade
News headline image
Boston Scientific Stock Hits A Record High, Consolidates. Prepping For Another Run? ↗
Boston Scientific stock rose to a record high in July and then consolidated. Prepping For a fresh run higher? 
Via Investor's Business Daily
Topics ETFs
News headline image
Stay informed with the top movers within the S&P500 index on Thursday. ↗
Let's delve into the developments on the US markets one hour before the close of the markets on Thursday. Below, you'll find the top gainers and losers within the S&P500 index during today's session. 
Via Chartmill
News headline image
Insulet (NASDAQ:PODD) Beats Expectations in Strong Q2, Stock Soars
Insulin delivery company Insulet Corporation (NASDAQ:PODD) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 32.9% year on year to $649.1 million. On top of that, next quarter’s... 
Via StockStory
News headline image
Insulet Lifts Annual Forecast On Increased Adoption For Insulin Pump Omnipod 5 ↗
Insulet beats Q2 estimates with strong Omnipod growth and lifts 2025 revenue outlook on rising adoption and expanding global customer base. 
Via Benzinga
News headline image
Exploring the top movers within the S&P500 index during today's session. ↗
Let's have a look at what is happening on the US markets in the middle of the day on Thursday. Below you can find the top S&P500 gainers and losers in today's session. 
Via Chartmill
News headline image
Applovin, Sunrun, Duolingo, Tutor Perini, Installed Building Products And Other Big Stocks Moving Higher On Thursday ↗
 
Via Benzinga
News headline image
Thursday's session: gap up and gap down stock in the S&P500 index ↗
Thursday's session is showcasing interesting market movements in the S&P500 index, with notable gap up and gap down stocks. Stay updated with the gapping S&P500 stocks in today's session. 
Via Chartmill
News headline image
Insulet (PODD) Q2 Revenue Jumps 33% ↗
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.